Merck (MRK) reported Q1 FY2023 earnings of $1.40 per share (versus $2.14 per share in Q1 FY2022), beating analysts’ consensus estimate of $1.34 per share.
The company’s quarterly revenues amounted to $14.48777 bln (-8.9% y/y), beating analysts’ consensus estimate of $13.807 bln.
MRK rose to $115.00 (+1.38%) in pre-market trading.
